The management of advanced thyroid cancer

Clinical Oncology

Volumn 16, Issue 8, 2004, Pages 561-568

  Wilson, P C ^a   Millar, B M ^b   Brierley, James D ^b  

^a BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Drug therapy; Radiotherapy; Thyroid neoplasms

Indexed keywords

ALPHA INTERFERON; ANALGESIC AGENT; CISPLATIN; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; INDIUM 111; IODINE 131; MONOCLONAL ANTIBODY; OCTREOTIDE; PACLITAXEL; RADIOACTIVE IODINE; SOMATOSTATIN DERIVATIVE; THYROGLOBULIN; THYROTROPIN;

ADVANCED CANCER; ANAPLASTIC CARCINOMA; ARTICLE; BEAM THERAPY; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; ESOPHAGUS STENOSIS; HUMAN; HYPERPIGMENTATION; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPHEDEMA; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; TELANGIECTASIA; THYROID CANCER; THYROIDECTOMY; TRACHEA STENOSIS;

HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 8744312650     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.08.009     Document Type: Article

References (92)

1. M.W. van den Brekel R.J. Hekkenberg S.L. Asa G. Tomlinson I.B. Rosen J.L. Freeman Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma Laryngoscope 107 1997 254-259
2. L.H. Sobin C. Wittekind TNM classification of malignant tumours 6th edn. 2002 John Wiley and Sons, New York
3. British Thyroid Association. Guidelines for the management of thyroid cancer in adults 2002 Royal College of Physicians, London, UK 1-70
4. L. Vini C. Harmer Radioiodine treatment for differentiated thyroid cancer [comment] Clin Oncol 12 2000 365-372
5. E.L. Mazzaferri S.M. Jhiang Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 97 1994 418-428
6. R. Vassilopoulou-Sellin H. Goepfert B. Raney P.N. Schultz Differentiated thyroid cancer in children and adolescents: Clinical outcome and mortality after long-term follow-up Head Neck 20 1998 549-555
7. I.D. Hay E.J. Bergstralh J.R. Goellner J.R. Ebersold C.S. Grant Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989 Surgery 114 1993 1050-1057, discussion 1057-1058
8. R.W. Tsang J.D. Brierley W.J. Simpson T. Panzarella M.K. Gospodarowicz S.B. Sutcliffe The effects of surgery, radioiodine and external radiation therapy on the clinical outcome of patients with differentiated thyroid cancer Cancer 82 1998 375-388
9. G.E. Sheline R.P. A'Hern M. Galante S. Lindsay Radiation therapy in the control of persistent thyroid cancer Am J Roentgenol Radium Ther Nucl Med 97 1966 923-930
10. W.J. Simpson S.E. McKinney J.S. Carruthers M.K. Gospodarowicz S.B. Sutcliffe T. Panzarella Papillary and follicular thyroid cancer Am J Med 83 1987 479-488
11. W.J. Simpson T. Panzarella J.S. Carruthers M.K. Gospodarowicz S.B. Sutcliffe Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients Int J Radiat Oncol Biol Phys 14 1988 1063-1075
12. M. Tubiana E. Haddad M. Schlumberger C. Hill P. Rougier D. Sarrazin External radiotherapy in thyroid cancers Cancer 55 1985 2062-2071
13. M. Tubiana M. Schlumberger P. Rougier et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma Cancer 55 1985 794-804
14. M. Tubiana Role of radioiodine in the treatment of local thyroid cancer Int J Radiat Oncol Biol Phys 36 1996 263-265
15. L.T. Wu S.D. Averbuch D.W. Ball A. de Bustros S.B. Baylin W.P. McGuire 3rd Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine Cancer 73 1994 432-436
16. M. O'Connell R.P. A'Hern C.L. Harmer Results of external beam radiotherapy in differentiated thyroid carcinoma: A retrospective study from the Royal Marsden Hospital Eur J Cancer 30A 1994 733-739
17. S.-M. Chow S.C.K. Law W.M. Mendenhall et al. Papillary thyroid carcinoma: Prognostic factors and the role of radioiodine and external radiotherapy Int J Radiat Oncol Biol Phys 52 2002 784-795
18. M.H. Jensen R.K. Davis L. Derrick Thyroid cancer: A computer-assisted review of 5287 cases Otolaryngol Head Neck Surg 102 1990 51-65
19. E.L. Mazzaferri An overview of the management of papillary and follicular thyroid carcinoma Thyroid 9 1999 421-427
20. N.A. Samaan P.N. Schultz R.C. Hickey et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients J Clin Endocrinol Metab 75 1992 714-720
21. G. Benker T. Olbricht D. Reinwein et al. Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherapy Cancer 65 1990 1517-1520
22. J.D. Brierley R.W. Tsang External-beam radiation therapy in the treatment of differentiated thyroid cancer Semin Surg Oncol 16 1999 42-49
23. O. Esik G. Nemeth J. Eller Prophylactic external irradiation in differentiated thyroid cancer: A retrospective study over a 30-year observation period Oncology 51 1994 372-379
24. J. Farahati C. Reiners M. Stuschke et al. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4) Cancer 77 1996 172-180
25. P. Phlips C. Hanzen G. Andry P. Van Houtte J. Fruuling Postoperative irradiation for thyroid cancer Eur J Surg Oncol 19 1993 399-404
26. D. Ford S. Giridharan C. McConkey et al. External beam radiotherapy in the management of differentiated thyroid cancer Clin Oncol 15 2003 337-341
27. J.D. Brierley R.W. Tsang T. Panzarella N. Bana Differentiated thyroid cancer: Analysis of prognostic factors and effect of treatment from a single institution on patients treated over forty years Thyroid 13 2003 S1
28. M.C. Coburn H.J. Wanebo Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer Am J Surg 164 1992 671-676
29. R. Vassilopoulou-Sellin P.N. Schultz T.P. Haynie Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy Cancer 78 1996 493-501
30. D. Casara D. Rubello G. Saladini et al. Distant metastases in diffentiated thyroid cancer: Longterm results of radioiodine treatment Tumori 77 1991 432-436
31. M. Schlumberger C. Challeton F. De Vathaire et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma J Nucl Med 37 1996 598-605
32. A.P. Brown W.P. Greening V.R. McCready H.J. Shaw C.L. Harmer Radioiodine treatment of metastatic thyroid carcinoma: The Royal Marsden Hospital experience Br J Radiol 57 1984 323-327
33. C.A. Proye D.H. Dromer B.M. Carnaille et al. Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine? World J Surg 16 1992 640-645 discussion 645-646
34. A.R. Shaha J.P. Shah T.R. Loree Differentiated thyroid cancer presenting initially with distant metastasis Am J Surg 174 1997 474-476
35. S.F. Dinneen M.J. Valimaki E.J. Bergstralh J.R. Goellner C.A. Gorman I.D. Hay Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades J Clin Endocrinol Metab 80 1995 2041-2045
36. E.T. Ekman G. Lundell J. Tennvall G. Wallin Chemotherapy and multimodality treatment in thyroid carcinoma Otolaryngol Clin North Am 23 1990 523-527
37. K. Shimaoka D.A. Schoenfeld W.D. DeWys R.H. Creech R. DeConti A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma Cancer 56 1985 2155-2160
38. B.R. Haugen Management of the patient with progressive radioiodine non-responsive disease Semin Surg Oncol 16 1999 34-41
39. T. Gruning C. Tiepolt K. Zophel J. Bredow J. Kropp W.G. Franke Retinoic acid for redifferentiation of thyroid cancer-does it hold its promise? Eur J Endocrinol 148 2003 395-402
40. N.J. Sarlis Metastatic thyroid cancer unresponsive to conventional therapies: Novel management approaches through translational clinical research [review] Curr Drug Targets Immune Endocr Metabol Disord 1 2001 103-115
41. E.L. Mazzaferri Changing paradigms in the follow-up of patients with differentiated thyroid cancer: An alternative to [18F]fluorodeoxyglucose positron emission tomographic scanning [comment] Endocr Pract 9 2003 324-326
42. B. Schluter K.H. Bohuslavizki W. Beyer M. Plotkin R. Buchert M. Clausen Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan [see comment] J Nucl Med 42 2001 71-76
43. F. Giammarile Z. Hafdi C. Bournaud et al. Is [18F]-2-fluoro-2-deoxy- d -glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake? Eur J Endocrinol 149 2003 293-300
44. M.P. Stokkel H.I. Reigman R.B. Verkooijen J.W. Smit Indium-111-octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131 J Cancer Res Clin Oncol 129 2003 287-294
45. F. Giammarile C. Houzard C. Bournaud Z. Hafdi G. Sassolas F. Borson-Chazot Diagnostic management of suspected metastatic thyroid carcinoma: Clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans Eur J Endocrinol 150 2004 277-283
46. F. Raue German medullary thyroid carcinoma/multiple endocrine neoplasia registry. German MTC/MEN Study Group. Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Type 2 Langenbecks Arch Surg 383 1998 334-336
47. N.A. Samaan P.N. Schultz R.C. Hickey Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy J Clin Endocrinol Metab 67 1988 801-805
48. L.E. Tisell G. Hansson S. Jansson H. Salander Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma Surgery 99 1986 60-66
49. J.D. Brierley R.W. Tsang M.K. Gospodarowicz S.B. Sutcliffe W.J. Simpson T. Panzarella Medullary thyroid cancer - analyses of survival and prognostic factors and the role of radiation therapy in local control Thyroid 6 1996 305-310
50. K.M. Fife M. Bower C.L. Harmer Medullary thyroid cancer: The role of radiotherapy in local control Eur J Surg Oncol 22 1996 588-591
51. A. Mak W. Morrison A. Garden N. Ordonez R. Weber L. Peters The value of postoperative radiotherapy for regional medullary carcinoma of the thyroid Int J Radiat Oncol Biol Phys 30 1994 234
52. T.D. Nguyen J.L. Chassard P. Lagarde et al. Results of postoperative radiation therapy in medullary carcinoma of the thyroid: A retrospective study by the French Federation of Cancer Institutes: The Radiotherapy Cooperative Group Radiother Oncol 23 1992 1-5
53. N. Fersht L. Vini R. A'Hern C. Harmer The role of radiotherapy in the management of elevated calcitonin after surgery for medullary thyroid cancer Thyroid 11 2001 1161-1168
54. E. Bajetta L. Rimassa C. Carnaghi et al. 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors Cancer 83 1998 372-378
55. M. Di Bartolomeo E. Bajetta A.M. Bochicchio et al. A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group Ann Oncol 6 1995 77-79
56. F. Orlandi P. Caraci A. Berruti et al. Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer Ann Oncol 5 1994 763-765
57. M. Schlumberger N. Abdelmoumene M.J. Delisle J.E. Couette Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC) Br J Cancer 71 1995 363-365
58. M. di Bartolomeo E. Bajetta R. Buzzoni et al. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group Cancer 77 1996 402-408
59. K. Frank-Raue R. Ziegler F. Raue The use of octreotide in the treatment of medullary thyroid carcinoma Horm Metab Res Suppl 27 1993 44-47
60. C. Mahler J. Verhelst M. de Longueville A. Harris Long-term treatment of metastatic medullary thyroid carcinoma with the somatostatin analogue octreotide Clin Endocrinol (Oxf) 33 1990 261-269
61. E. Modigliani R. Cohen S. Joannidis et al. Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma Clin Endocrinol (Oxf) 36 1992 183-186
62. G. Lupoli E. Cascone F. Arlotta et al. Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon alpha-2b and octreotide Cancer 78 1996 1114-1118
63. T.M. Behr R.M. Sharkey M.E. Juweid et al. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG J Nucl Med 38 1997 858-870
64. M.E. Juweid G. Hajjar R. Stein et al. Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR J Nucl Med 41 2000 93-103
65. R. Stein M. Juweid C.H. Zhang D.M. Goldenberg Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer Clin Cancer Res 5 1999 3199s-3206s
66. M. Drosten B.M. Putzer Gene therapeutic approaches for medullary thyroid carcinoma treatment J Mol Med 81 2003 411-419
67. K.B. Ain Anaplastic thyroid carcinoma: Behavior, biology, and therapeutic approaches Thyroid 8 1998 715-726
68. K.B. Ain Anaplastic thyroid carcinoma: A therapeutic challenge Semin Surg Oncol 16 1999 64-69
69. B.F. van der Laan J.L. Freeman R.W. Tsang S.L. Asa The association of well-differentiated thyroid carcinoma with insular or anaplastic thyroid carcinoma: Evidence for dedifferentiation in tumor progression Endocr Pathol 4 1993 215-221
70. D.P. Byar S.B. Green P. Dor et al. A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group Eur J Cancer 15 1979 1033-1041
71. E.J. Junor J. Paul N.S. Reed Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy Eur J Surg Oncol 18 1992 83-88
72. C.J. Nel J.A. van Heerden J.R. Goellner et al. Anaplastic carcinoma of the thyroid: A clinicopathologic study of 82 cases Mayo Clin Proc 60 1985 51-58
73. C. Passler C. Scheuba G. Prager et al. Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis Langenbecks Arch Surg 384 1999 284-293
74. P.E. Voutilainen M. Multanen R.K. Haapiainen A.K. Leppaniemi A.H. Sivula Anaplastic thyroid carcinoma survival World J Surg 23 1999 975-978, discussion 978-979
75. J.G. Demeter S.A. De Jong A.M. Lawrence E. Paloyan Anaplastic thyroid carcinoma: Risk factors and outcome Surgery 110 1991 956-961 discussion 961-953
76. O. Nilsson J. Lindeberg J. Zedenius et al. Anaplastic giant cell carcinoma of the thyroid gland: Treatment and survival over a 25-year period World J Surg 22 1998 725-730
77. J. Tennvall G. Lundell A. Hallquist P. Wahlberg G. Wallin S. Tibblin Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group Cancer 74 1994 1348-1354
78. J. Tennvall G. Lundell P. Wahlberg et al. Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery Br J Cancer 86 2002 1848-1853
79. G. Mitchell R. Huddart C. Harmer Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma Radiother Oncol 50 1999 33-38
80. C.S. Wong J. Van Dyk W.J. Simpson Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma Radiother Oncol 20 1991 3-9
81. J.D. Brierley R.W. Tsang External radiation therapy in the treatment of thyroid malignancy Endocrinol Metab Clin North Am 25 1996 141-157
82. P.I. Haigh P.H. Ituarte H.S. Wu et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival Cancer 91 2001 2335-2342
83. B. McIver I.D. Hay D.F. Giuffrida et al. Anaplastic thyroid carcinoma: A 50-year experience at a single institution Surgery 130 2001 1028-1034
84. C.Y. Lo K.Y. Lam K.Y. Wan Anaplastic carcinoma of the thyroid Am J Surg 177 1999 337-339
85. R.K. Tan R.K. Finley 3rd D. Driscoll V. Bakamjian W.L. Hicks Jr. D.P. Shedd Anaplastic carcinoma of the thyroid: A 24-year experience Head Neck 17 1995 41-47, discussion 47-48
86. M. Schlumberger C. Parmentier M.J. Delisle J.E. Couette J.P. Droz D. Sarrazin Combination therapy for anaplastic giant cell thyroid carcinoma Cancer 67 1991 564-566
87. K.B. Ain M.J. Egorin P.A. DeSimone Treatment of anaplastic thyroid carcinoma with paclitaxel: Phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group Thyroid 10 2000 587-594
88. J.D. Brierley R.W. Tsang External radiation therapy in the treatment of thyroid cancer [review] Endocrinol Metab Clin North Am 25 1996 141-157
89. C. Harmer M. Bidmead S. Shepherd A. Sharpe L. Vini Radiotherapy planning techniques for thyroid cancer Br J Radiol 71 1998 1069-1075
90. C.M. Nutting D.J. Convery V.P. Cosgrove et al. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland Radiother Oncol 60 2001 173-180
91. T.H. Kim D.S. Yang K.Y. Jung C.Y. Kim M.S. Choi Value of external irradiation for locally advanced papillary thyroid cancer Int J Radiat Oncol Biol Phys 55 2003 1006-1012
92. J.H. Kim R.D. Leeper Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy Cancer 60 1987 2372-2375